Date published: 2026-5-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

APOBEC3B Activators

APOBEC3B Activators belong to a class of chemical compounds designed to modulate the activity of APOBEC3B, a member of the APOBEC (apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like) family of cytidine deaminase enzymes. APOBEC3B plays a pivotal role in the innate immune response against viral infections and functions by introducing mutations in the genetic material of invading viruses, such as retroviruses and hepatitis B virus. These mutations disrupt viral replication and reduce infectivity. APOBEC3B primarily targets viral DNA or RNA by catalyzing the deamination of cytidine or deoxycytidine to uridine, leading to hypermutation and rendering the viral genome nonfunctional. APOBEC3B Activators are synthesized with the aim of selectively interacting with APOBEC3B, influencing its enzymatic activity, substrate specificity, or interactions with viral nucleic acids, although the specific mechanisms can vary among different compounds within this chemical class.

The activation or modulation of APOBEC3B by these compounds can impact the host's defense against viral infections. APOBEC3B, along with other APOBEC family members, constitutes a critical component of the intrinsic immune system and contributes to the control of viral replication. Its ability to introduce mutations in the viral genome provides an effective defense mechanism against a wide range of viruses. APOBEC3B Activators serve as valuable research tools for scientists studying innate immunity, viral infections, and the molecular mechanisms by which host cells combat viral pathogens. They allow researchers to explore how modulating APOBEC3B activity may influence the host's antiviral defense mechanisms and the coevolutionary arms race between viruses and their host organisms.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$94.00
$213.00
33
(5)

Methotrexate may influence APOBEC3B expression through its impact on DNA synthesis and cellular replication processes.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

This compound could affect APOBEC3B expression by altering intracellular signaling pathways, particularly those related to mood and behavior.

Cisplatin

15663-27-1sc-200896
sc-200896A
100 mg
500 mg
$138.00
$380.00
101
(4)

Cisplatin may modulate APOBEC3B expression as a response to DNA damage and repair mechanisms.

Valproic Acid

99-66-1sc-213144
10 g
$87.00
9
(1)

As a histone deacetylase inhibitor, it might affect chromatin remodeling and gene expression, potentially influencing APOBEC3B levels.

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$176.00
$426.00
43
(3)

This compound could alter APOBEC3B expression through its interaction with DNA and transcriptional control.

Tamoxifen

10540-29-1sc-208414
2.5 g
$272.00
18
(2)

As a selective estrogen receptor modulator, it may impact APOBEC3B expression through hormone-mediated signaling pathways.

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$91.00
$139.00
$374.00
36
(1)

This corticosteroid might influence APOBEC3B expression through its effects on inflammation and immune response regulation.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$111.00
$357.00
8
(0)

Known for its immunomodulatory effects, it could alter APOBEC3B expression through its impact on cytokine production and immune response.

Cyclophosphamide

50-18-0sc-361165
sc-361165A
sc-361165B
sc-361165C
50 mg
100 mg
500 mg
1 g
$90.00
$146.00
$469.00
$791.00
18
(1)

As an alkylating agent, it may affect APOBEC3B expression through its impact on DNA cross-linking and cell cycle regulation.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

This immunosuppressant might influence APOBEC3B expression through its role in mTOR signaling and cellular growth regulation.